Bordeaux Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bordeaux Wealth Advisors's PFE Position: Q2 2025 in Review
Bordeaux Wealth Advisors increased its Pfizer (PFE) stake by 32% in Q2 2025, buying an estimated $78.8K and bringing the position to 13,939 shares worth $338K. The position accounts for 0.04% of the portfolio, ranked #119.
Bordeaux Wealth Advisors first reported a position in PFE in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.21M in Q4 2021. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Bordeaux Wealth Advisors held 13,939 shares of Pfizer worth $338K as of Q2 2025.
- Bordeaux Wealth Advisors bought 3,377 Pfizer shares in Q2 2025, an estimated $78.8K.
- Pfizer made up 0.04% of Bordeaux Wealth Advisors's portfolio in Q2 2025, its #119 holding.
- Bordeaux Wealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 18 quarters since.
- Bordeaux Wealth Advisors's Pfizer position peaked at $1.21M in Q4 2021.
- 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Bordeaux Wealth Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.